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Introduction {#sec001}
============

In a population of sexually reproducing organisms, a significant sex bias towards males is predicted to decrease the population's overall reproductive output. One factor is the fecundity of females, the sex with a lower rate of gamete production, which can exert a large influence on the size of a population. Forcing the sex-ratio towards males has thus long been regarded as a potential avenue for the genetic control of harmful insect pest or disease-vector populations. While the introduction of various forms of female-killing genetic traits could achieve this goal, more powerful strategies have also been theorized. Hamilton, for example, speculated that a population of a heterogametic species would become increasingly male-biased if, at each generation a mutant Y chromosome would favour its transmission over the X-chromosome. The decline in female numbers would result in a reduced population size and eventually the collapse of the population \[[@pgen.1008647.ref001]\]. Hamilton's thinking was inspired by records of distorter traits in *Aedes aegypti* and *Culex pipiens* that can produce extreme sex-ratios of \>90% males. Cytological observations during male meiosis showed broken X-chromosomes suggesting a causal link with the male-bias phenotype \[[@pgen.1008647.ref002], [@pgen.1008647.ref003]\]. These findings inspired the generation of artificial distorter traits \[[@pgen.1008647.ref004]\] first by using His-Cys box homing endonucleases and subsequently RNA-guided endonucleases. In the malaria vector *Anopheles gambiae* (*A*. *gambiae*) autosomal I-PpoI \[[@pgen.1008647.ref005]\] or CRISPR/Cas9-bearing transgenes \[[@pgen.1008647.ref006]\] were used to target sequences on the X-chromosome during male meiosis. Even if these autosomal X-shredders were self-limiting and thus less invasive and powerful compared to a driving Y chromosome, cage experiments with I-PpoI induced extreme male-biased sex-ratios and population collapse confirming the potential of this system for genetic control.

Mechanistically, the nature of the target locus for which successful X-shredding was demonstrated suggested a possible coalescence of different effects in the mosquito system. The target sites are situated within the *A*. *gambiae* 28S rDNA cluster which simultaneously represents (i) a high-copy number repeat on the X-chromosome, (ii) an essential gene for ribosome biogenesis and function, (iii) the nucleolar organizing region of the cell as well as (iv) a sequence adjacent to the centromere of the X-chromosome and (v) the predicted pseudo-autosomal region of the X-chromosome mediating pairing with the Y chromosome during meiosis \[[@pgen.1008647.ref007]\]. The possible conflation of effects induced by X-shredding in the mosquito has been a source of uncertainty regarding the potential to transfer this paradigm to other important pest species. In particular, the X-shredding approach has not been clearly delineated from a related, recently-proposed strategy, based on the targeting of X-linked haploinsufficient genes (commonly ribosomal genes) with the intent to induce female lethality \[[@pgen.1008647.ref008]\]. To delineate this mechanism, which is assumed not to alter gamete production and to come into effect only in the developing progeny, we refer to it as X-poisoning. X-poisoning would also generate a male biased progeny but would be expected to lead to a significant loss of reproductive output in the form of inviable female embryos. Reduced hatching is however a feature of the mosquito sex distortion system in some transgenic strains \[[@pgen.1008647.ref009]\]. Although experiments suggested that carry over of endonuclease protein rather than insufficiency of the rDNA was responsible for this zygotic lethality \[[@pgen.1008647.ref004]\], a contribution of altered target gene function to this effect could not be ruled out completely.

Here, we have sought to disentangle and reconstitute these two strategies in *Drosophila melanogaster* by targeting with CRISPR/Cas9 both X-linked multicopy repeats and, in parallel, X-linked putative haplolethal genes essential for ribosome function. By doing so we have also sought to demonstrate that the X-shredding mechanism is transferable, in principle, between species and between target genes and has potential applications beyond malaria vector control. We have also explored the efficiency of X-poisoning in biasing the sex-ratio as an alternative strategy for genetic control.

Results {#sec002}
=======

Assessing Cas9 and LbCpf1 activity of transgenic strains {#sec003}
--------------------------------------------------------

Due to the inadequacies of the Gal4/UAS system for directing transgene expression in later stages of spermatogenesis \[[@pgen.1008647.ref010]\], we first generated multiple strains by random or site-directed transgenesis where the *cas9* or *cpf1* (*cas12a*) coding sequences were placed under the direct transcriptional control of the *βtub85D* promoter. This regulatory element drives high expression of genes exclusively in the male germline, during the primary spermatocyte stage (at the onset of Meiosis I) and, as demonstrated in the mosquito \[[@pgen.1008647.ref004], [@pgen.1008647.ref005]\], this is the stage with the strongest evidence of X-shredding activity. To evaluate CRISPR function, we first crossed *βtub85D-*endonuclease bearing strains to flies containing a gRNA transgene targeting the X-linked, single copy *white* gene, used here as a phenotypic marker (gRNAs *w_ex3_2* for Cas9 and *w_ex3_1* for Cas12a/LbCpf1 were used respectively) \[[@pgen.1008647.ref011]\]. The mutation of *white* results in individuals with white eyes due to a lack of pigment and we compared the activity of the different lines by counting the fraction of offspring with white eyes ([S1 Fig](#pgen.1008647.s001){ref-type="supplementary-material"}, [S1 Table](#pgen.1008647.s004){ref-type="supplementary-material"}). In the progeny of the transheterozygotes we found variability in mutation frequencies ranging from 25.5% with *βtub85D-cas9*^*20D*^ (on the X chromosome) to 52.2% with *βtub85D-cas9*^*20F*^ (on the third chromosome) likely due to differing expression levels of the endonuclease transgene. In addition, the level of activity of all the *βtub85D* driven lines was significantly lower when compared to *cas9* driven by the *nanos* (*nos*) promoter using the same gRNA (96.7% white eyes). LbCpf1 showed low levels of activity (0.6% white eyes) and for our further experiments we exclusively utilized Cas9. Unless specifically indicated, we used the *βtub85D-cas9*^*20F*^ insertion on chromosome 3, which yielded the highest *white* mutation frequency of 52.2% for all experiments.

Identification of X-linked target sequences {#sec004}
-------------------------------------------

To identify X-linked sequences which could be targeted by CRISPR/Cas9 in the male germline we used two different approaches. First, using publicly available short read and long read *Drosophila* datasets, we employed the Redkmer pipeline \[[@pgen.1008647.ref012]\] which we previously developed to identify putative X-linked repeat sequences that were not also present on other chromosomes from raw sequence data alone ([S2 Fig](#pgen.1008647.s002){ref-type="supplementary-material"}). From the set of kmers of 25 nucleotides that passed our criteria including abundance, X-linkage, and the lack of predicted off-target cleavage, we selected 8 target sequences for gRNA design located in multiple sites across the X-chromosome ([S2](#pgen.1008647.s002){ref-type="supplementary-material"} and [S3](#pgen.1008647.s003){ref-type="supplementary-material"} Figs). These target repeat sequences were predicted each to be confined to single chromosomal regions with the 5 most abundant sequences all located within annotated genes (*esi-2*.*1*, *muc14a*, *hydra*, *CG33235* and *CG15040*). We made no assumption about the higher-order structure or the conservation of these putative repeat sequences between individuals, although all chosen gRNA repeat targets were also predicted to be multicopy sequences on the X when we searched the DmelR6.01 genome assembly ([Fig 1B](#pgen.1008647.g001){ref-type="fig"}) and all mapped exclusively to scaffold X1 of a recent heterochromatin-enriched genome assembly \[[@pgen.1008647.ref013]\] ([S2 Table](#pgen.1008647.s005){ref-type="supplementary-material"}). The maximum predicted abundance of the top repeat sequences by the assemblies (155 hits) or redkmer (232 hits) suggests that the target repeats in *Drosophila* would be less repetitive than the target in *Anopheles*, i.e. the 28S rDNA cluster with an array in excess of 500 repeats per genome. In a second approach, we identified putative haploinsufficient genes \[[@pgen.1008647.ref014]\], on the *Drosophila* X-chromosome and designed four gRNAs targeting conserved regions within the *RpS5a* \[[@pgen.1008647.ref015]\] and *RpS6* \[[@pgen.1008647.ref016]\] ribosomal protein genes.

![**Development of sex ratio distorters in *Drosophila* (A)** Model for pre-zygotic and post-zygotic effects on the reproductive sex-ratio. Compared to the unaltered process of development (top), an endonuclease targeting the X-chromosome during spermatogenesis (bottom) could either negatively affect the production or function of X-bearing sperm (i, prezygotic effect) or introduce genetic modifications that are detrimental to females inheriting such modified X-chromosomes during development (ii, postzygotic effect; e.g. the mutation of haploinsufficient genes). Pink: X-chromosome bearing gamete. Cyan: Y chromosome bearing gamete. The asterisk indicates gametes bearing modifications at the target site. **(B)** gRNA target sequences used in this study and their positions on the X-chromosome. The protospacer-adjacent motif (PAM) is indicated in red, and the X-chromosome hits predicted by Redkmer and the number of predicted perfect BLASTn hits to the X-chromosome in the *Drosophila* genome assembly (Dmel R6.01) are indicated. **(C)** Schematic of the experimental crosses. Females bearing the *cas9* transgene were crossed to males carrying the *gRNA* transgene. Trans-heterozygote males were then crossed to wild-type females. Cas9 in concert with the gRNA cleaves the X-chromosome at the target site (green asterisk) in the germline and the effect is measured as the sex-ratio of the progeny. A: autosome; X: X-chromosome, Y; Y-chromosome. **(D)** Male sex-ratios in the offspring from crosses of *βtub85D-cas9/gRNA* with wild-type *w* females. Progeny of *βtub85D-cas9/+* males crossed to wild type females (no gRNA) or from the reverse cross (*βtub85D-cas9/gRNA* females crossed to wild type males = female control) served as a control. Crosses were set as pools of males and females or as multiple male single crosses in which case error bars indicate the mean ± SD for a minimum of ten independent single crosses. For all crosses n indicates the total number of individuals (males + females) in the F1 progeny counted. P-values \*p \< 0.05, \*\*\*\*p \< 0.0001. All crossing data can be found in [S3 Table](#pgen.1008647.s006){ref-type="supplementary-material"}.](pgen.1008647.g001){#pgen.1008647.g001}

Characterization of sex distorting gRNAs {#sec005}
----------------------------------------

All gRNAs were cloned downstream of the RNA Polymerase III promoter of the *Drosophila* U6 snRNA gene that drives ubiquitous expression and we generated independent strains for all selected gRNAs. In addition, we also generated lines that combined either 2 different gRNAs using double dU6 promoters or 4 gRNAs expressed as a single transcriptional tRNA-gRNA array \[[@pgen.1008647.ref017], [@pgen.1008647.ref018]\]. The *βtub85D-cas9* and each gRNA line were crossed to obtain trans-heterozygous males expressing both Cas9 and the gRNA in the germline where activity is expected to occur. Next, these individuals were crossed to wild type females to determine the sex-ratio of their offspring ([Fig 1C](#pgen.1008647.g001){ref-type="fig"}). As a control, we either used *βtub85D-cas9* alone or the reciprocal cross that, due to the lack of *βtub85D* activity in females, was not expected to express Cas9. [Fig 1D](#pgen.1008647.g001){ref-type="fig"} ([S3 Table](#pgen.1008647.s006){ref-type="supplementary-material"}) summarizes the results of these experiments performed with a pool of individuals or by crossing single males to three females. We noted that while most gRNAs targeting X-linked repeats did not substantially affect the sex-ratio, the *Muc14a_6* gRNA induced a highly significant male-biased sex-ratio of 61.5% (p \< 0.0001). This level of distortion was consistently observed in the follow-up experiments. Of those gRNAs targeting putative X-linked haplolethal genes, two gRNAs, *RpS6_2* and *Rps5a_1*, yielded a significant excess of male progeny with frequencies of 93.8% (p \< 0.0001) and 56.6% (p = 0.0112), respectively. We first focused our attention on the *Muc14a_6* gRNA that we hypothesized to induce sex-ratio distortion by the X-shredding mechanism. The *Muc14a_6* gRNA maps to the *Mucin 14A* (*Muc14a*, CG32580), an accessory-gland gene of unknown function that spans 52.6 kilobases and contains extended regions of tandemly repeated sequences (see also [Fig 3A](#pgen.1008647.g003){ref-type="fig"}). The target repeats fall within the coding sequence of the gene with a predicted 271 nucleotides between individual *Muc14a_6* gRNA target sites. We tested four gRNAs, each targeting different but interspersed repeat sequences in the *Muc14a* gene and found that only one yielded significant sex distortion. *Muc14a_6* gRNA produced an excess of male progeny even if its target was not predicted to be the one with the highest number of hits in the cluster ([Fig 1B](#pgen.1008647.g001){ref-type="fig"}, [S2 Table](#pgen.1008647.s005){ref-type="supplementary-material"}). To exclude the possibility that a loss of *Muc14a* gene function is the cause of the sex-ratio distortion, we also designed two gRNAs, *Muc14a_1* and *Muc14a_2*, targeting putative non-repetitive regions in the *Muc14a* coding sequence. These experiments showed that the function of the *Muc14a* gene was not responsible for the male-biased sex-ratio observed in the progeny ([Fig 1D](#pgen.1008647.g001){ref-type="fig"}).

We performed *in-vitro* Cas9 cleavage assays and our results suggested that all gRNAs targeting repeat sequences within the Muc14a locus were active *in-vitro*. For this purpose, we amplified and cloned a fragment of 1395 bp of the Muc14a cluster that contained between 2 and 4 target sites for each of the four *Muc14a* gRNAs ([Fig 2A](#pgen.1008647.g002){ref-type="fig"}) that served as a substrate for *in-vitro* digestions. We therefore concluded that the observed difference in their effects must be due to (i) different intrinsic or *in-vivo* gRNA performance, (ii) the particular nature or context of the target sequence or (iii) the specific repair outcomes triggered. We next tested combinations of gRNAs targeting the same or different X-linked repeat clusters to evaluate whether these could improve sex distortion rates ([Fig 2B](#pgen.1008647.g002){ref-type="fig"}; [S4 Table](#pgen.1008647.s007){ref-type="supplementary-material"}). While we observed a modest boost by providing an additional Cas9 source, neither combination of gRNAs including the transcriptional array of four gRNAs resulted in a higher distortion than that of the single *Muc14a_6* gRNA alone. We also observed that the *w_ex3_2* gRNA targeting *white*, when encoded as the most 3' of four consecutive gRNAs within the tRNA-gRNA array, showed a dramatically reduced level of activity ([S1 Fig](#pgen.1008647.s001){ref-type="supplementary-material"}). In flies expressing both *Muc14a_6* and *hydra_1* gRNAs from separate loci we observed comparable distortion to that of *Muc14a_6* gRNA alone. Interestingly, we observed no sex-ratio distortion when *nos*-*cas9* males, expressing the *Muc14_6* gRNA, were crossed to wild type females. This result is in stark contrast with *nos-cas9* showing substantially higher levels of activity than *βtub85D-cas9* when combined with the *white* gRNA ([S1 Fig](#pgen.1008647.s001){ref-type="supplementary-material"}). As previously hypothesized \[[@pgen.1008647.ref004]\], these findings support the idea that X-shredding is dependent on the timing of Cas9 activity, with expression in early spermatocytes also working well in the mosquito system. An analysis of *Drosophila* development in the progenies of *βtub85D-cas9/+*, *βtub85D-cas9/Muc14a_6* and wild type fathers confirmed that the *Muc14a_6* gRNA induced no significant zygotic lethality---over any fitness effect of *βtub85D-cas9* alone---an outcome expected if the loss of females is due to X-shredding acting pre-zygotically ([Fig 2C](#pgen.1008647.g002){ref-type="fig"}; [S5 Table](#pgen.1008647.s008){ref-type="supplementary-material"}).

![**(A)** Assay to detect CRISPR/Cas9-mediated cleavage *in vitro*. The region of the Muc14a gene that was amplified contains at least 2 binding sites for each of the gRNAs: *Muc14a*\_3, *Muc14a_4*, *Muc14a_5* and *Muc14a_6* (top). The PCR amplified DNA fragment was used as a digestion target for Cas9*/*gRNA cleavage reactions *in vitro* (bottom). Reactions were run on a gel to detect cleavage. A control without gRNA was included. **(B)** Analysis of combinations of gRNAs and Cas9 sources for X-shredding. Average male frequencies in the F1 progeny are shown for each parental genotype with a single copy of *βtub85D-cas9* transgene (1X), two copies of *βtub85D-cas9* transgene (2X) or one copy of *nos-cas9* (grey bars). All lines were crossed to wild type *w* individuals. The reciprocal cross (female ctrl) or heterozygote *βtub85D-cas9/+* or *nos-cas9/+* without gRNA (no gRNA) were used as control. The black arrow indicates gRNAs in the multiplex array and the red dotted line indicates an unbiased sex-ratio. Crosses were set as pools of males and females or as multiple male single crosses in which case error bars indicate the mean ± SD for a minimum of ten independent single crosses. For all crosses n indicates the total number of individuals (males + females) in the F1 progeny counted. **(C)** Developmental survival analysis of the F1 progeny of *Muc14a_6/βtub85D-cas9* males crossed to *w* females compared to *w* and *βtub85D-cas9/+* control males crossed to *w* females. Left columns: embryos to pupae survival rate; central columns: pupae to adults survival rate and right columns: fraction of males and females in adults. Bars indicate means ± SD for at least ten independent single crosses. Statistical significance was calculated with a *t* test assuming unequal variance. \*\*p \< 0.01, \*\*\*p\< 0.001 and \*\*\*\*p\< 0.0001. **(D)** Influence of DNA repair and fusome integrity on X-shredding. Male frequencies in the progeny of *DNAlig4*^*57*^ (red), *spn-A*^*057*^ (green) and *spn-A*^*093*^ (orange) mutants and *UAS_α-spectrinRNAi*; *nos-GAL4* (yellow) knockdown mutants. The F1 sex-ratio of the progeny of males carrying *Muc14a_6/βtub85D-cas9* in the mutant backgrounds was compared with those of *βtub85D-cas9/+* (grey), *Muc14a_6/ βtub85D-cas9* (cyan) and *nos-GAL4/+* (purple) control males. Each dot represents the percentage of F1 males from a cross between one male and three females. n is the number of individuals (males + females) in the F1 progeny. Bars show means ± SD for at least ten independent single crosses. Statistical significance was calculated with a *t* test assuming unequal variance. \*\*\*\*p\< 0.0001. All crossing data in [S3 Table](#pgen.1008647.s006){ref-type="supplementary-material"}.](pgen.1008647.g002){#pgen.1008647.g002}

X-shredding in backgrounds with impaired DNA repair activity or intracyst communication {#sec006}
---------------------------------------------------------------------------------------

To better understand the cellular mechanisms that influence the outcome of X-shredding, i.e. loss of X-bearing gametes and a bias towards males in the progeny, we generated lines bearing mutations in DNA repair pathway components or core components of the fusome. The *DNA Ligase IV* gene (*lig 4*; CG12176) encodes an ATP-dependent DNA ligase involved in non-homologous end joining (NHEJ) DNA repair; *spindle-A* (*spn-A*; CG7948) is a *Drosophila* homolog of the Rad51 gene required for double-strand break (DSB) repair by homologous recombination (HR) in both somatic and germ cells and α-*spectrin* (α-*spec*; CG1977) encodes for a component of the fusome, an organelle that facilitates intracyst cell communications during spermatogenesis \[[@pgen.1008647.ref019]--[@pgen.1008647.ref021]\]. The fusome has also been implicated in the coordinated intracyst cell death response following DNA damage and mediating protein transport and diffusion between connected sperm cells, a process on which X-shredding in hemizygote individuals may rely on \[[@pgen.1008647.ref004], [@pgen.1008647.ref021]\]. We found that the disruption of NHEJ repair by the mutant *lig4*^*57*^ significantly increased the level of male-bias to above 68%, whereas *spn-A* mutants and α-*spec* dsRNAi did not affect the sex-ratio significantly ([Fig 2D](#pgen.1008647.g002){ref-type="fig"}; [S6 Table](#pgen.1008647.s009){ref-type="supplementary-material"}).

Analysis of the Muc14a cluster by amplicon sequencing {#sec007}
-----------------------------------------------------

To gain a more accurate understanding of the DNA repair mechanisms acting during X-shredding we performed sequencing of the *Muc14a* repeat cluster before and after it had undergone modification by Cas9. We crossed the *Muc14a_6* gRNA strain to both, *βtub85D-cas9* and *nos-cas9* flies to examine the outcomes of activity at different stages of spermatogenesis. However, since F1 females inherit modified X-chromosomes from their fathers and unmodified X-chromosomes from their mothers, it is difficult to assess the exact level of gene editing on paternal X-chromosomes. To overcome this obstacle, we crossed *βtub85D-cas9/Muc14a_6* or *nos-cas9/Muc14a_6* male individuals to X\^X/Y females with attached-X-chromosomes \[[@pgen.1008647.ref022]\]. By doing this, single modified X-chromosomes are passed from fathers to sons and can be analysed by amplicon sequencing ([Fig 3A](#pgen.1008647.g003){ref-type="fig"}). In control males, \~90% of repeats contained the full gRNA target site ([Fig 3B](#pgen.1008647.g003){ref-type="fig"}, panel 1) although polymorphisms in the surrounding sequence indicated that the Muc14a cluster shows substantial heterogeneity. We found that, on average, X-chromosomes inherited from *βtub85D-cas9/Muc14a_6* fathers showed a \> 40% reduction of cleavable gRNA target sites ([Fig 3B](#pgen.1008647.g003){ref-type="fig"}, panel 1) but surprisingly this value was over 85%, on average, in those X-chromosomes derived from *nos-cas9/Muc14a_6* males, despite the fact that no sex-ratio distortion had been observed with this combination. X-chromosomes of *βtub85D-cas9/Muc14a_6* fathers had, on average a larger number of unique alleles (identified from mapping reads that lacked the gRNA at the target site) than the wild type. By contrast, the progeny of *nos-cas9/Muc14a_6* showed a reduction of allele diversity, when considering alleles represented in ≥ 1% of mapping reads ([Fig 3B](#pgen.1008647.g003){ref-type="fig"}, panel 2). A similar pattern was observed when we considered alleles with a read coverage above 10X, where X-chromosomes derived from *βtub85D-cas9/Muc14a_6* males showed a more diverse repeat landscape compared to control and *nos-cas9/Muc14a_6* males ([Fig 3B](#pgen.1008647.g003){ref-type="fig"}, panel 3). We analysed in more detail the fate of pre-existing alleles in the control males ([Fig 3C](#pgen.1008647.g003){ref-type="fig"}) as well as novel alleles presumably generated by CRISPR/Cas9 activity ([Fig 3D](#pgen.1008647.g003){ref-type="fig"}). While consensus allele frequency decreased in males of the experimental groups, we found a pre-existing allele predicted to be cleavage-resistant (AACAaATCAAGAGGAAACATCaG, with mutations in both the target site and the PAM), to increase in median frequency from \<1% to \~25% in males from *βtub85D-cas9/Muc14a_6* but not from *nos-cas9/Muc14a_6* fathers ([Fig 3C](#pgen.1008647.g003){ref-type="fig"}, row 3). In contrast, novel CRISPR-induced alleles, likely generated pseudo-randomly, were commonly shared amongst a few males, although their mapping reads accounted for more than 40% of all reads in some males from *nos-cas9/Muc14a_6* fathers ([Fig 3D](#pgen.1008647.g003){ref-type="fig"}). On the sequence level, CRISPR-induced alleles consisted mainly of smaller deletions at or around the site of cleavage and all would be predicted to prevent further Cas9 cleavage. Together these findings suggest quite different dynamics of repair or repair mechanisms between the early acting *nos-cas9* and the meiotic *βtub85D-cas9*.

![**(A)** Schematic of the genetic crosses to obtain shredded X-chromosomes from *Muc14a_6/βtub85D-cas9* or *Muc14a_6/nos-cas9* fathers for amplicon sequencing. Trans-heterozygous males for *cas9* and the *gRNA* were crossed to females with attached-X-chromosomes (X\^X). Offspring with supernumerary or lacking X-chromosomes are inviable leaving X\^X/Y females and males carrying the X-shredded chromosome (patroclinous inheritance) which we selected and analysed. Genomic DNA from single males was extracted and a 153 bp DNA motif containing the *Muc14a_6* gRNA target site was amplified with primers (thin arrows on repeats) containing Illumina Sequence adapters (grey boxes flanking the amplicon). As a comparison we used DNA from *βtub85D-cas9*/+ individuals lacking the gRNA. The shredded X-chromosome is indicated by a green asterisk. A dashed red circle indicates males selected for amplicon sequencing. Vertical black bars represent the number and location of the *Muc14a_6* gRNA repeats within the *Muc14a* gene. **(B)** Analysis of allele variation at the *Muc14a_6* target site by amplicon sequencing. Indicated is the percentage of all mapped reads that contain the complete, unaltered *Muc14a_6* target site (left panel) in the control and experimental males. The middle and right panel show the number of reads harbouring all other unique alleles that represented at least 1% of all reads or were represented by 10 or more reads, respectively. **(C)** Analysis of unique alleles (including the wild type target site) at the *Muc14a_6* target site that pre-existed in both control samples. Indicated are the relative frequencies of these alleles in each control and experimental male (circles) including the median frequency of each allele in all *Muc14a_6/βtub85D-cas9* or *Muc14a_6/nos-cas9* males (squares). **(D)** Analysis of *de-novo* alleles at the *Muc14a_6* target site not present in control males and putative CRISPR-induced alleles. In C and D we considered only alleles that represented ≥1% of normalized reads in at least one male sample.](pgen.1008647.g003){#pgen.1008647.g003}

Targeting putative haplolethal X-linked genes {#sec008}
---------------------------------------------

We next focussed our analysis on the set of gRNAs targeting putative haploinsufficient single-copy genes. As we observed for gRNAs targeting the Muc14a repeats, no combination of gRNAs with *βtub85D-cas9* was found to increase the sex-ratio relative to the *RpS6_2* gRNA alone. Both gRNAs, *RpS5a_1* and *RpS6_2*, when crossed to *βtub85D-cas9* were individually capable of inducing male-bias sex-ratio distortion, but when combined within a gRNA array, we found a significantly lower level of distortion in the progeny than when we used *RpS6_2* alone ([Fig 4B](#pgen.1008647.g004){ref-type="fig"}; [S7 Table](#pgen.1008647.s010){ref-type="supplementary-material"}). In contrast to X-shredding, X-poisoning is expected to act post-zygotically by inducing female lethality in the developing embryo likely as a result of an insufficient dose of the target-gene product. We examined *Drosophila* development in the progenies of *βtub85D-cas9/+*, *βtub85D-cas9/RpS6_2* and wild type fathers and, in contrast to the *Muc14a_6* gRNA, we did observe significant lethality at the embryonic and subsequent stages. This result would suggest a mechanism of lethality that operates during development and that the few survivor females in the progeny carried rescue mutations that restored the function of the ribosomal target genes, while preventing further CRISPR cleavage. To confirm this hypothesis, we performed amplicon sequencing of the *RpS6_2* target sequence using 2 pools of the surviving females from *βtub85D-cas9* fathers expressing the *RpS6_2* or *RpS6_2* and *RpS6_1* gRNAs ([Fig 4C](#pgen.1008647.g004){ref-type="fig"}; [S8 Table](#pgen.1008647.s011){ref-type="supplementary-material"}). Surprisingly, while we did observe possible rescue alleles, the majority of mutant alleles identified in surviving females are not expected to restore *RpS6* gene function because of the presence of translational frameshifts ([Fig 4D](#pgen.1008647.g004){ref-type="fig"}). Although, one has to be cautious to infer loss of function from such experiments alone \[[@pgen.1008647.ref023]\], these results imply that the mechanism of lethality following *RpS6* cleavage and imperfect repair is dominant rather than dependent on an insufficient gene dose. Co-expression of *Muc14_6* and *Rps6_2* gRNAs, i.e. combining the two mechanism of distortion we have described, yielded the highest level of distortion we observed in this study (on average 95.8% males) although this was not significantly different from *RpS6_2* alone. Finally, when we combined the *Rps6_2* gRNAs with *nos-cas9* the result was complete sterility of the transheterozygous males (Supplementary Dataset 1). Since ribosomal gene function is required during gametogenesis, disrupting *RpS6* during the stem cell stages appears to be detrimental for sperm development.

![**(A)** gRNA target sites within presumptive haploinsufficient genes on the X-chromosome. Schematic representation of *RpS5a* and *RpS6* gene organization. Both genes encode for a small ribosomal subunit protein (RpS). As illustrated in the figure, the *RpS5a* gRNAs, *RpS5a_1* and *\_2*, map in the fourth exon shared by all four transcripts of the gene and the *RpS6* gRNAs, *RpS6_1* and *2*, map in the third exon of two transcripts in the corresponding gene. The figure shows the 234 bp fragment (with Illumina Sequence adapters on both sides as grey boxes) surrounding the *RpS6*\_2 gRNA target site that was used for amplicon sequencing. Blue boxes indicate coding sequences, white boxes indicate UTR regions and PAMs are indicated in red. **(B)** Efficiency of single gRNAs or combinations of gRNAs for X-poisoning. Shown is the frequency of males in the progeny from *βtub85D-cas9* males combined with four *gRNA* lines and crossed to wild type *w* females. Individual gRNAs, *RpS5a_1* or *RpS5a \_2 (*red), and *RpS6_1* or *RpS6_2* (orange) are compared to double gRNA arrays co-expressing *RpS6_2 + RpS5a_1* (green) or *RpS6_2 + RpS6_1* (purple) as well as a combination of both *RpS6_2* and *Muc14a_6* transgenes (pink). As a control, crosses from *βtub85D-cas9/+* (no gRNA, grey) fathers are shown. Each dot represents the percentage of F1 males from a cross between one male and three females. n is the number of individuals (males + females) in the F1 progeny. Black bars show means ± SD for at least ten independent single crosses. Statistical significance was calculated with a *t* test assuming unequal variance. \*\*p \< 0.01, \*\*\*p\< 0.001 and \*\*\*\*p\< 0.0001. All crossing data can be found in [S7 Table](#pgen.1008647.s010){ref-type="supplementary-material"}. **(C)** Developmental survival analysis of the F1 progeny of *RpS6_2/βtub85D-cas9*, *w* or *βtub85D-cas9/+* males crossed to *w* females. Left columns: embryos to pupae survival rate; central columns: pupae to adults survival rate and right columns: fraction of males and females in adults. Bars indicate means ± SD for at least ten independent single crosses. Statistical significance was calculated with a *t* test assuming unequal variance. \*\*p \< 0.01, \*\*\*p\< 0.001 and \*\*\*\*p\< 0.0001. All crossing data can be found in [S8 Table](#pgen.1008647.s011){ref-type="supplementary-material"}. **(D)** CRISPR induced target site mutations within the *RpS6* gene analysed by pooled amplicon sequencing of surviving female progeny. On top, the wild type DNA sequence spanning the *RpS6_2* gRNA target site in the *RpS6* ribosomal gene is shown with the gRNA binding position (underline), the cut site (red arrowhead), the PAM (bold nucleotides) as well as the encoded amino acids (blue). Target site variants identified in pools of F1 females from *RpS6_2/βtub85D-cas9* fathers or *RpS6_2 RpS5a_1/βtub85D-cas9* fathers are shown below. Dashed lines correspond to nucleotide deletions, green coloured bases represent insertions. Predicted amino-acid substitutions (\>) are indicated to the right.](pgen.1008647.g004){#pgen.1008647.g004}

Discussion {#sec009}
==========

To recreate in *Drosophila* a synthetic X-shredding mechanism pioneered in *A*. *gambiae*, we generated gRNAs targeting repeat sequences we identified on the X-chromosome. This demonstrates that X-shredding is a transferable mechanism and not linked to the particular nature of the mosquito target, i.e. the ribosomal DNA gene cluster that was targeted in previous studies \[[@pgen.1008647.ref005], [@pgen.1008647.ref006]\]. It also shows that CRISPR/Cas9 target sequences that are able to induce sex-ratio distortion can be identified bioinformatically. To search for such X-linked repeats, we employed the Redkmer pipeline using raw sequence data as the only input. This is crucial as many target species of medical or agricultural importance are likely to lack high-quality genome assemblies. Even when such assemblies exist, repeats sequences, a problematic class of sequences for assemblers, often remain poorly resolved. However, recent progress in telomere-to-telomere chromosome assemblies that incorporate large DNA repeat clusters may simplify this step in the future \[[@pgen.1008647.ref024]\]. The level of sex distortion towards males we observed in the fly was not as extreme as observed in *A*. *gambiae*. Given that activity against the single-copy *white* was incomplete this suggests possible improvements by further optimizing the level of *cas9* expression in the germline of *Drosophila*. Using our best *cas9* strain, we found that achieving higher rates of distortion required us to interfere with mechanisms of DNA repair. This in turn indicates that targeting more repetitive sequences could be another avenue to enable a more dramatic bias towards males, though the *Drosophila* X-chromosome lacks such repeats. The smaller repeat unit size and hence smaller distance between individual cut sites (271 base pairs in the case of *Muc14a_6* versus \~9kb in the *A*. *gambiae* rDNA target) could also have increased the chances of successful repair. In addition to the intrinsic activity of each gRNA, the sequence microenvironment rather than the number of repeats may also play a role in determining why certain gRNAs trigger gamete loss while others don't. The identification of X-chromosomes which are more suitable for X-shredding in target species of medical or agricultural relevance is thus the next task. Our study provides lessons for the application of X-shredding to such species. A strong meiotic promoter yielding high levels of Cas9 should be combined with as few gRNAs as possible, ideally one, targeting a highly repetitive sequence, which does not have to be essential and can consist of a single repeat cluster on the X-chromosome.

Chromosome-wide, distributed repeats represent an alternative set of targets but the lack of such sequences in *Drosophila* precluded us from evaluating their use for X-shredding. The fly literature suggests that the 1.688 X-chromosome satellite involved in X dosage compensation \[[@pgen.1008647.ref025]\] one of the most abundant repetitive sequences in *Drosophila melanogaster*, would represent such a target \[[@pgen.1008647.ref026]\]. While the set of candidate targets did include a number of kmers that could be attributed to the 1.688 satellite they did not pass our selection criteria or were significantly less abundant than the targets we selected. This is likely due to the heterogeneity and stratification of 1.688 repeats in various chromosomal locations \[[@pgen.1008647.ref027]\].

Although the use of larger arrays of gRNAs has been suggested to compensate for the lack of abundant X-linked repeats \[[@pgen.1008647.ref006]\], our data suggests that targeting a highly repetitive sequence with a single gRNA may be a more viable route. Even if multiple gRNAs could be expressed efficiently and concomitantly, they could compete for access to Cas9 protein in the loading step thus reducing activity of each individual gRNA. The saturation of Cas9 by gRNAs has been observed previously \[[@pgen.1008647.ref028]\].

Our data suggests that the high level of activity of *nos-cas9* with *Muc14a_6* gRNA during early spermatogenesis could cause the repeats to be subject to multiple cleavage-repair cycles which in turn may lead to the observed reduction in the complexity and presumably also the size of the repeat cluster (and no sex bias). By contrast, *βtub85D-cas9/Muc14a\_*6 activity, which acts later in meiosis, would encounter, following multiple mitotic divisions, more X-chromosomes to target in the larger population of primary spermatocytes on which it may be acting continuously and in parallel to generate novel alleles. This would result in a broader spectrum of mutations inherited by the progeny. Alternatively, the observed differences could also partly relate to the predominance of homologous over non-homologous DNA repair pathways acting with varying stringency during the early (including stem cells) and late stages of spermatogenesis, respectively \[[@pgen.1008647.ref029]\] or an overall greater repair efficiency in pre-meiotic stages compared to later stages when *βtub85D-cas9* is active. While *nos-cas9* would favour the loss of repeat units by recombination-based repair mechanism, *βtub85D-cas9* would trigger NHEJ repair events leading to a more diverse allele pool. Indeed, we found little evidence of homologous repeat to repeat repair in *βtub85D-cas9/Muc14a_6* males. For instance, the pre-existing cleavage-resistant allele AACAaATCAAGAGGAAACATCaG is associated with a 6bp indel polymorphism located 53 nucleotides upstream of the gRNA target. We did not detect dissociation of this SNP even in samples in which the cleavage resistant allele rose to a frequency of 30% of the mapped read pool. Dissociation would have indicated that a double-strand break in a wild-type repeat unit had been repaired by gene conversion using the cleavage resistant allele as a template.

One caveat is the fact that the X-chromosomes from *βtub85D-cas9/Muc14a_6* males we analysed by amplicon sequencing managed to escape the germline in the form of X-bearing gametes and gave rise to viable males. One might argue that they represent chromosomes with an overall lower level of modifications or modifications with repair outcomes compatible with transmission and male survival (which may in turn differ from the requirements for female survival). In contrast, the X-chromosomes unable to form viable gametes, i.e. those that we could not analyse by sequencing the surviving progeny, may be the ones that underpin the sex distortion observed, and may be subject to fundamentally different repair events.

A number of questions remain to be answered, such as the mechanism through which X-shredding causes the loss of X-bearing gametes and how insufficient or incomplete DNA repair is associated with this process. This outcome is by no means self-evident; for example, it has been shown that functional sperm can be produced despite lacking either one or both major autosomes or lacking DNA \[[@pgen.1008647.ref030]\]. The fly model of X-shredding we have established will allow to tackle these questions experimentally. Much remains to be understood also before X-shredders could move towards application. For example, CRISPR-induced X chromosome rearrangements or pathways for the evolution of cleavage-resistant repeats are areas that have not been sufficiently explored.

We also established an X-poisoning system in the *Drosophila* model by targeting X-linked ribosomal genes and achieved high rates of male bias. This latter strategy, in the form of a Y-linked endonuclease, has recently been proposed as an efficient alternative to gene drives for genetic control \[[@pgen.1008647.ref008]\]. Modelling suggests Y-linked editors would outperform other self-limiting strategies while having less impact on non-target populations when compared to gene drives or driving Y-chromosomes. We found the mechanism of embryo lethality in the case of the ribosomal *RpS6* gene to be more complex than anticipated. Rather than protein dose insufficiency, a dominant lethal effect may partially or totally explain our results. Such an effect in mutated ribosomal proteins has been observed previously \[[@pgen.1008647.ref031]\] and could, for example, be explained by the poisoning of ribosomes with dysfunctional ribosomal proteins. Since, in this case, every escaper female represents only a single repair event, phenotypes would be expected to vary depending on the outcome of DNA repair. Another possibility to explain the survival of females with frameshift mutations in the target gene is that the haplolethality of RpS6 could be time-dependent so that after passing a "critical" stage of development, e.g. embryo development, the gene becomes haplosufficient. Further modelling may be required to understand how these phenotypes would impact genetic control at the population level.

The X-shredding and the X-poisoning transgenes we have described here could be expressed from the *Drosophila* Y chromosome which has recently been modified to harbour pre-characterized gRNA sites for transgene insertion \[[@pgen.1008647.ref032]\]. This could allow, for the first time, to explore the use of such Y-linked editors with gRNAs for X-poisoning or X-shredding. To what degree these two strategies could be designed around or would be susceptible to X-chromosome inactivation in the male germline of *Drosophila* is a further research question, in particular as this process is not fully understood in the fly \[[@pgen.1008647.ref033], [@pgen.1008647.ref034]\]. In both strategies timing of expression appears key and too early expression---when Cas9 was driven by the *nos* promoter---was unsuccessful, resulting in no distortion for the X-shredding and male sterility for the X-poisoning strategy.

Nevertheless, the application of X-poisoning to agriculturally or medically relevant species would appear to be a more straightforward proposition in particular as ribosomal target genes show high levels of conservation and because lower levels of Cas9 activity for cleaving a single target site per chromosome may suffice. Also, the characterization of Y chromosomes and the identification of male determining regions \[[@pgen.1008647.ref007], [@pgen.1008647.ref035], [@pgen.1008647.ref036]\] and docking sites \[[@pgen.1008647.ref032]\] within which to land transgenes has recently made great progress.

Materials and methods {#sec010}
=====================

Identification of candidate kmers for X-shredding {#sec011}
-------------------------------------------------

Error-corrected PacBio reads derived from males of the ISO1 strain (ref doi: [10.1038/nbt.3238](https://doi.org/10.1038/nbt.3238)) were obtained from the University of Maryland Center for Bioinformatics and Computational Biology (<http://gembox.cbcb.umd.edu/mhap/data/dmel.polished.fastq.gz>). Illumina reads from males and females of the same strain were obtained from the NCBI short read archive (female: SRX826515 and male: SRX826516). These were used as inputs to run Redkmer \[[@pgen.1008647.ref012]\]. The mitochondrial genome (NCBI accession number: NC_024511) was used to filter out mitochondrial derived reads. We only considered Pacbio reads between 2kb and 100kb to improve chromosome quotient accuracy (CQ--\[[@pgen.1008647.ref037]\]) and excluded kmers occurring less than 4 times in the combined male and female Illumina data. We applied a number of critera to the 25,298 candidate X-kmers predicted by Redkmer to be X-linked abundant sequences. First, we used FlashFry \[[@pgen.1008647.ref038]\] to select among the candidate X-kmers, those that contained a sequence suitable for the design of a Cas9 gRNA. To estimate off-target potential, we used as a reference all PacBio reads predicted by Redkmer to represent autosomal and Y derived sequences. We then applied several additional metrics such as the maximum number of occurrences of a kmer per PacBio read, giving an estimate of the repeat size, and the total number PacBio reads containing the kmer at least once, giving an estimate of the abundance of the repeat across the X-chromosome. Kmers shortlisted for testing were selected based on the following cutoffs: abundance in the genome (coverage in combined male and female Illumina data \>log~10~(2), coverage in PacBio data \>log~10~(1), the maximum kmer hits per PacBio read \> 7.5, and at least 5 perfect blast hits to the assembled genome. All candidate X-kmers were also re-assembled into longer contigs using the Geneious Software (Geneious Assembler allowing no mismatches) to identify possible higher-order repeat loci and to ensure that different sequence classes would be targeted in our experiments. A total of 8 of 205 X-kmers passing all filters were then selected for testing in transgenic strains.

Generation of transgenic lines {#sec012}
------------------------------

### Design and assembly of constructs {#sec013}

Unless otherwise noted, cloning was performed with the NEBuilder Hi Fi DNA Assembly kit (New England Biolabs). PCR reactions were performed with the Phusion High-Fidelity PCR Master Mix with HF buffer (New England Biolabs). All inserts were verified by sequencing (GENEWIZ). Primers used for plasmid construction are listed in [S9 Table](#pgen.1008647.s012){ref-type="supplementary-material"}.

### *βtub85D-cas9* expression plasmid {#sec014}

The previously described plasmid *pYSC47w*^*-*^ harbouring the *3Px3-eGFP* transformation marker, *attB* and *piggyBac* recombination sequences (a gift from Andrea Crisanti, Imperial College London) was used to build *Drosophila cas9* constructs. The plasmid was linearized with *Sbf*I. A 478 bp DNA fragment of *βtub85D* 5' regulatory region was amplified with primers *βtub85D F/βtub85D-cas9-R* from the genomic DNA of *Drosophila* strain *w*^*1118*^. The human codon-optimized *cas9* coding sequence including two nuclear localization signals (*SV40 NLS* at the 5' and *nucleoplasmin NLS* at the 3') was amplified from *hcas9* (a gift from George Church; Addgene plasmid \# 41815; <http://n2t.net/addgene:41815>; RRID:Addgene_41815) using primers *βtub85D-cas9-F/cas9-βtub56D-3\'UTR-R* \[[@pgen.1008647.ref039]\]. A third DNA fragment of 651 bp in the *βtub56D* 3'-UTR region was amplified with primers casβtub56F/βtub56D R from the plasmid *pYSC61*. The three fragments were cloned in the open backbone of *Sbf*I-linearized *pYSC47w*^-^ resulting in the final plasmid termed *"pYSC47w+\_βtub85D_cas9_βtub56D"*. The plasmid was used for both *piggyBac* and *attP*-docking site integration.

### *βtub85D-Lbcpf1* expression plasmid {#sec015}

To generate the plasmid expressing *Lbcpf1*, fragments containing the *βtub85D* promoter and the *βtub56D* 3'-UTR were amplified from the construct *pYSC47w+\_βtub85D_cas9_βtub56D*. The fragment containing the *Lbcpf1* coding sequence was amplified from *pY016 hLbcpf1* (Addgene plasmid \# 69988; <http://n2t.net/addgene:69988>; RRID:Addgene_69988) \[[@pgen.1008647.ref040]\]. The three fragments were finally assembled in *Sbf*I-digested *pYSC47w*^*-*^.

### Guide RNA expression plasmid {#sec016}

All single guide RNAs were cloned in *Bbs*I-linearized *pCFD3-dU6*:*3 gRNA* plasmid (a gift from Simon Bullock; Addgene plasmid \# 49410; <http://n2t.net/addgene:49410>; RRID:Addgene_49410) \[[@pgen.1008647.ref017]\] and harbouring a U6 promoter. A gRNA array containing *Muc14a_4*, *hydra_1*, *esi2*.*1_1* and *w_ex3_2*, in this order, was assembled with the oligos *Array1_cas9_PCR1_F*, *Array1_cas9_PCR1_R*, *Array1_cas9_PCR2_F*, *Array1_cas9_PCR2_R* and *Array1_cas9_PCR3_R* and cloned in *pCFD5* plasmid (a gift from Simon Bullock; Addgene plasmid \# 73914; <http://n2t.net/addgene:73914>; RRID:Addgene_73914) \[[@pgen.1008647.ref018]\]. Two distinct arrays, each containing two gRNAs targeting ribosomal genes, were assembled with primers *RpS6 2_pCFD4_F* and *RpS6\_ 1_pCFD4_R* for the *RpS6_2 + RpS6_1* array and *RpS6_2\_pCFD4_F* and *RpS5a_1\_pCFD4_R* for the *RpS6_2 + RpS5a_1* array. The arrays were cloned in *pCFD4-U6*:*1_U6*:*3* tandem gRNAs plasmid (a gift from Simon Bullock; Addgene plasmid \# 49411; <http://n2t.net/addgene:49411>; RRID:Addgene_49411). The plasmids *pCFD3*, *pCFD4* and *pCFD5* were all integrated in *attP*-docking sites. CRISPR target site design. CHOPCHOP v2 was used to choose gRNA target sites in *RpS6* and *RpS5a* ribosomal genes specific regions in *Drosophila* genome (dm6).

### Embryo injections {#sec017}

Embryo injections were carried out at the University of Cambridge Fly Injection Facility. The *βtub85D_cas9* constructs were inserted at the *P{CaryP}attP40* site on the 2nd chromosome (25C6; Stock 13--20) and the *PBac{y*^*+*^*-attP-9A}VK00027* on the 3rd chromosome (89E11; Stock 13--23), both stocks marked with *yellow*^*+*^. Moreover, the *βtub85D_cas9* plasmid was integrated in *D*. *melanogaster* by piggyBac transposition. Transgenic flies were balanced with *w*^*1118*^*; if/CyO* and *w*^*1118*^*; TM3*, *Sb/TM6B*. Different lines were generated with *βtub85D_cas9* integrated on the X (20D), on the second (20G) and on the third chromosome (20F). gRNAs cloned in *pCFD3*, *pCFD4* or *pCFD5* were integrated in the genome at the *P{CaryP}attP40* site on the second (Bloomington stock 25709) and/or *P{CaryP}attP2* site on the third chromosome (Bloomington stock 25710). *pCDF4_RpS6_2\_RpS6_1*, *pCDF4_RpS6_2\_RpS5a_1*, *pCFD3_w\_ex3-2*, *pCFD3_RpS6_gRNA2*, *pCFD3_RpS6_gRNA1*, *pCFD3_Muc14a_1*, *pCFD5_Cas9_Array1*, *pCFD3_CG33235_1*, *pCFD3_CG15040_1*, *pCFD3_Hydra_1*, *pCFD3_Muc14a \_4*, *pCFD3\_ Muc14a_3*, *pCFD3\_ Muc14a_3*, *pCFD3\_ Muc14a_5*, *pCFD3\_ Muc14a_6*, and *w_ex3-1* (LbCpf1) were inserted in the *P{CaryP}attP2* site on the third chromosome and *pCFD3_RpS5a_gRNA1*, *pCFD3_RpS5a_gRNA2*, *pCFD3\_ Muc14a_2*, *pCFD3_Hydra_1*, *pCFD3\_ Muc14a_3*, *pCFD3\_ Muc14a_5*, *and pCFD3\_ Muc14a_6* were inserted in the *P{CaryP}attP40* site on the second chromosome.

Fly husbandry and strains {#sec018}
-------------------------

Flies were maintained under standard conditions at 25°C with a 12/12 hour day and night cycle. For general maintenance, stocks were provided with new food every 2--3 weeks. Flies were anesthetized with CO~2~ during phenotyping. To assess fluorescent green eyes phenotype conferred by the *3PX3*::*eGFP* transgene, we used a conventional fluorescence microscope. Description of stocks not provided here can be found in FlyBase ([http://flybase.org](http://flybase.org/)). The lines used in this study were: *DNAlig4*^*57*^ Bloomington Stock \#8520, *Spn-A*^*057*^ and *Spn-A*^*093*^ a gift from Mitch McVey (Tuft University), Df(3R)XF3 Bloomington Stock \#2352, *UAS-α-spectrinRNAi* Bloomington Stock \#56932 (TRIP.HMC04371), *nanos_Gal4* Bloomington Stock \#4937, *C(1)DX/FM6* (compound chromosome with attached X-chromosomes*)* Bloomington stock \#784.

Analysis of *βtub85D-cas9* and *nos-cas9* activity {#sec019}
--------------------------------------------------

To test *attP* or *piggyBac* integrated *βtub85D-cas9* and *nos-cas9* efficiencies, females from each line were crossed to *w*^*+*^; *w_ex3-2* gRNA males bearing a gRNA targeting the *white* gene on the X-chromosome. Red eye trans-heterozygous *w*^*+*^*; cas9*/*w_ex3-2* F1 males were selected, crossed to *w*^*1118*^ females and the percentage of white eye females in the progeny was recorded.

Genetic crosses for X-shredding and X-poisoning {#sec020}
-----------------------------------------------

During the initial screen for X-shredding-induced sex ratio distortion, *βtub85D-cas9* mothers were crossed to each gRNA line (from a 25 nucleotides kmer), in a vial at 25°C. At least twenty trans-heterozygous F1 *gRNA/+*; *βtub85D-cas9/+* males for each combination of sgRNA were then crossed to the same number of *w*^*-*^ females in new vials at the same temperature. We used the reverse crosses, *βtub85D-cas9/sgRNA* females crossed to *w*^*-*^ males, as controls due to the lack of *βtub85D* activity in females. We discarded the gRNA lines that did not result in sex ratio distortion while those where we recorded a male bias progeny were further tested by pursuing single cross analysis. For every single cross, a single trans-heterozygous *βtub85D-cas9/+; gRNA/+* male (experiment) and a heterozygous *βtub85D-cas9/+* male (control) were crossed to three wild-type females in separate vials at 25°C. We set up a minimum of ten single crosses for each genotype analysed. For all crosses where we analysed the change in male bias in the progeny of *βtub85D-cas9/+; Muc14a_6/+* in a NHEJ, HDR or fusome mutant backgrounds, we set up ten-twenty replicas of single male crosses, i.e., *w DNAlig4*^*57*^*; Muc14a_6/βtub85D-cas9*^*20F*^ single male X three *w* females, *Muc14a_6/βtub85D-cas9*^*20G*^*; Spn-A*^*093\ or\ 057*^*/Df(3R)XF3* single male X three *w* females and *UAS-α-spectrinRNAi/Muc14a_6; βtub85D-cas9*^*20F*^*/nanos_Gal4* single male X three *w* females and compared the results to the progenies of *Muc14a_6/βtub85D-cas9* and *βtub85D-cas9/+* single male crosses used as controls.

In all crosses for X-poisoning-induced sex ratio distortion, *βtub85D-cas9* mothers were crossed to each gRNA analysed, in a vial. Single F1 *βtub85D-cas9/+; gRNA/+* (experiment) and *βtub85D-cas9/+*(control) males were then crossed to three wild-type females in separate vials. We set up a minimum of ten single crosses for each genotype to generate means and standard deviations for statistical comparisons and thus measure consistency and robustness of the results. All crosses were done at 25°C. Percent of males and females was calculated as the ratio between the number of individuals counted and the number of individuals expected for each genotype. Flies were scored and examined with the Nikon SMZ1500 stereomicroscope equipped with a CoolLED *p*E-300 Led fluorescent illumination.

*In vitro* cleavage assay {#sec021}
-------------------------

The *Muc14a_3*, *Muc14a_4*, *Muc14a_5* and *Muc14a_6* gRNAs were tested for *in vitro* activity using the Guide-it sgRNA *In Vitro* Transcription and Screening System (Takara Bio USA, Inc.). Each gRNA was transcribed and purified according to the *In Vitro* Transcription of sgRNA protocol. Two experiments were performed, allowing transcription to take place for 4 and 8 hours. Genomic DNA templates were obtained from Muc14a fragments previously cloned in a *pMiniT 2*.*0* vector using PCR Cloning Kit (NEB) and primers kmer Muc14_F and 58537687_F. The genomic target was amplified by PCR with Cloning Analysis Forward and Reverse Primers, mapping in the *pMiniT 2*.*0* plasmid. The amplicon corresponds to a genomic fragment of 1395 bp and sequencing confirmed the presence of target sites for all 4 gRNAs. For *in-vitro* digestions the DNA was excised from an agarose gel and purified with Monarch DNA Gel Extraction Kit (NEB). DNA concentration and absorbance ratio were measured with a NanoDrop Spectrophotometer (ThermoScientific). PCR amplification of target DNA and a Cas9 cleavage assay were then carried out according to the protocol.

Amplicon sequencing analysis preparation {#sec022}
----------------------------------------

Genomic DNA was isolated from ten single F1 males originated from the cross *βtub85D_cas9*^*20F*^*/Muc14a_6* X *C(1)DX/FM6* (compound chromosome with attached X-chromosomes*)* Bloomington stock \#784 and from one control male from the cross *w/Y; βtub85D_cas9*^*20F*^*/ TM6B* using the QIAamp DNA Micro Kit. Genomic loci containing the *Muc14a_6* gRNA target site were amplified with Phusion HF DNA polymerase (Thermo Scientific) using *Repeat 56910823_illumina_F* and *Repeat_Muc14a_3\_illumina_R* primers containing the Illumina adapters. 200 ng of genomic DNA in a 100 μl reaction volume were used as a template for a limiting PCR reaction to amplify 153 bp of slightly different repeats in the *Muc14a* gene. To maintain the proportion of reads corresponding to particular repeats, the PCR reactions were performed under non-saturating conditions for a total of 25 cycles with 55°C annealing temperature.

For deep sequencing analysis of the ribosomal gene *RpS6* target site, the genomic DNA was extracted from a pool of four daughters from the cross *βtub85D_cas9*^*20F*^*/RpS6_2* X *w*, four daughters from the cross *βtub85D_cas9*^*20F*^*/RpS6_2 + RpS5a_1* X *w* and from the *βtub85D_cas9*^*20F*^/+ daughter control. The primers RpS6_1F and RpS6_1R were used to amplify a 234 bp DNA fragment spanning the *RpS6_2* target site. The amplicons were purified with NEB Monarch PCR & DNA Cleanup Kit and quantified with Nanodrop. 200 ng were checked on a gel and 500 ng were sent to GENEWIZ to be sequenced with NGS-based amplicon sequencing. We ran CRISPResso \[[@pgen.1008647.ref041]\] software on raw sequencing data to detect mutations at the target site using parameter -q 30, setting the minimum average read quality score (phred33) to 30.

Viability studies {#sec023}
-----------------

To identify the developmental stage at which the progeny from *Muc14a_6/βtub85D_cas9* and *RpS6_2/βtub85D_cas9* crossed to *w*^*1118*^ die, we quantified egg hatching, pupae and adult death rates in the F1. To quantify the egg hatching rate, 20--30 heterozygous *Muc14a_6/βtub85D_cas9* or *RpS6_2/βtub85D_cas9* and 20--30 *w*^*1118*^ virgin females were set up in embryo collection cages with grape juice agar plates and yeast paste. Two different embryo collection cages with *w*^*1118*^ and *βtub85D\_*cas9/+ males crossed to *w*^*1118*^ females served as a comparison control. Between four and six collections of 70--200 embryos each, were performed for each genotype. Every embryo collection was transferred in a separate fly vial and followed for over 36 h to count the number of embryos that did not hatch, the number of pupae, and female and male adults. Percent survival to each stage was calculated as the ratio between the number of individuals counted and the number of individuals expected for each genotype. The data for the two experiments and for each of the crosses are shown in Table [Fig 2C](#pgen.1008647.g002){ref-type="fig"} and Table [Fig 4C](#pgen.1008647.g004){ref-type="fig"} in supplementary Dataset 1.

Supporting information {#sec024}
======================

###### Evaluation of Cas9 activity when expressed from *βtub85D-cas9* and *βtub85D_cpf1* transgenes integrated at various genomic locations (chromosome indicated in parentheses) using ϕC31 (*attP)* or *piggyBac* mediated transformation.

Flies carrying *βtub85D-cas9* expressed from *attP* docking \#15--1 on the second and \#10--1 and \#4 on the third chromosomes and from piggyBac mediated random integrations \#20D on the X, \#20 G on the second and \#20F and \#20C on the third chromosomes were crossed to lines transgenic for *w_ex3-2* gRNA that targets the *white* gene on the X-chromosome. *βtub85D-cas9*/*w_ex3-2* F1 males with red eyes were then crossed to *white* mutant females, and the female progeny scored for white eyes. Experiments combining two *βtub85D-cas9* transgenes with the *w_ex3-2* gRNA and *βtub85D-cas9* with *w_ex3-2* expressed as part of a gRNA multiplex array were also performed. Similarly, *βtub85D_cpf1/w_ex3-1* red eye males were crossed to *white* females, and the female progeny scored for white eyes. Along with the *βtub85D* promoter, the *nanos*-*cas9* transgene efficiency was tested with the same *w_ex3-2* gRNA. gRNAs used for each experiment are shown below the graph. n is the number of individuals (males + females) in the F1 progeny.

(TIF)

###### 

Click here for additional data file.

###### Candidate X-kmer abundance and chromosomal distribution.

**(A)** Coverage of all candidate X-kmers (grey dots) including those X-kmers chosen for experimental evaluation (colored dots) within the Illumina and PacBio whole-genome sequencing read datasets as predicted by Redkmer. **(B)** Genomic distribution of all candidate X-kmers (grey dots) and those selected X-kmers for experimental testing (colored dots) on *D*. *melanogaster* chromosome arms based on perfect complementarity. The X-axis indicates the Mbp position of matches on each chromosomal arm, including the 4^th^ chromosome, unmapped contigs and heterochromatin (\_*h*).

(TIF)

###### 

Click here for additional data file.

###### Kmer sub-selection applied to Redkmer output.

Criteria for candidate kmer selection (X-axes) are shown for each of the eight selected X-kmers for X-shredding (colored dots) and for the remaining candidate X-kmers (grey dots). Red vertical lines highlight the minimum cutoff values imposed for the final target site selection. Density plots of each criteria are also shown for the entire Redkmer candidate X-kmer output. The part of the kmer sequence that represents the target sites of experimental gRNAs is indicated (underline).

(TIF)

###### 

Click here for additional data file.

###### Reported in the table are the numbers and percentages of female progenies from different genetic crosses using one or two *cas9* or the *cpf1* endonucleases driven by either the *βtub85D* or the *nanos* promoters, to assess the efficiency of cleavage in the *white* gene.

All crosses are between males bearing the endonuclease and the sgRNA, *w_ex3-2* and *w_ex3-1* for *cas9* and *cpf1* respectively, and females of the *white* genotype. Different *βtub85D-cas9* lines, generated by *attP* or *piggyBac* integrations, are compared. The *Array1_1* is a multiplex of 4 different gRNAs (*Muc14a_4*, *hydra_1*, *esi-2*.*1_1* and *w_ex3-2*).

(XLSX)

###### 

Click here for additional data file.

###### Predicted perfect blastn hits of kmer target sequences for X-shredding within the *Drosophila melanogaster* heterochromatin-enriched genome assembly \[[@pgen.1008647.ref013]\].

(XLSX)

###### 

Click here for additional data file.

###### Reported in the table are the numbers and percentages of male and female progenies from genetic crosses between of *βtub85D-cas9/gRNA* and wild-type *w* females to assess the sex-ratio.

sgRNA lines are complementary to single (*Muc14a_1*, *Muc14a_2*, *RpS6_1*, *RpS6_2*, *RpS5a_1* and *RpS5a_2*) or multiple hits on the X chromosome. Progeny of *βtub85D-cas9/+* males crossed to wild type females (no gRNA) or from the reverse cross (*βtub85D-cas9/gRNA* females crossed to wild type males = female control) were used as control. Crosses were set as pools of males and females or as multiple male single crosses for a minimum of ten independent single crosses.

(XLSX)

###### 

Click here for additional data file.

###### Analysis of combinations of gRNAs and Cas9 sources for X-shredding. Reported in the table are the numbers and percentages of males and females in the progeny from genetic crosses between of *βtub85D-cas9/gRNA* and wild-type *w* females.

Average frequencies (%) and standard deviations (STDEV) are shown for each parental genotype with a single copy of *βtub85D-cas9* transgene (1X), two copies of *βtub85D-cas9* transgene (2X) or one copy of *nos-cas9* (grey bars). All lines were crossed to wild type *w* individuals. The reciprocal cross (female ctrl) or heterozygote *βtub85D-cas9/+* or *nos-cas9/+* without gRNA (no gRNA) were used as control. Crosses were set as pools of males and females or as multiple male single crosses for a minimum of ten independent crosses.

(XLSX)

###### 

Click here for additional data file.

###### Survival analysis of the F1 progeny of *Muc14a_6/βtub85D-cas9* males crossed to *w* females compared to *w* and *βtub85D-cas9/+* control males crossed to *w* females.

F1 embryos were collected six, five and four times from cages containing males of the genotype *Muc14a_6/βtub85D-cas9*, *+/βtub85D-cas9* or *white* respectively, crossed to *white* females. The table shows the numbers of embryos, hatched embryos, pupae, females, males and total adults for each collection. The table also shows the percentages of pupae on collected embryos, adults on pupae, and frequencies of males and females on adults.

(XLSX)

###### 

Click here for additional data file.

###### Influence of DNA repair and fusome integrity on X-shredding.

The table shows male and female numbers, frequencies (%) and standard deviation (STDEV) in the F1 of *Muc14a_6/βtub85D-cas9* males with *DNAlig4*^*57*^, *spn-A*^*057*^ or *spn-A*^*093*^ mutations crossed to *white* females. Also shown are the F1 female and male frequencies for the cross of *UAS_α-spectrinRNAi*; *nos-GAL4* (yellow) knockdown mutants. At least ten independent single crosses per experiment were performed and each cross was between one male and three females.

(XLSX)

###### 

Click here for additional data file.

###### Efficiency of single gRNAs or combinations of gRNAs for X-poisoning.

The table shows the numbers of males, females and percentage of males in the progeny from *βtub85D-cas9* males combined with *gRNA* lines and crossed to wild type *white* females. Individual gRNAs, *RpS5a_1* or *RpS5a \_2*, and *RpS6_1* or *RpS6_2* or double gRNA arrays co-expressing *RpS6_2 + RpS5a_1* or *RpS6_2 + RpS6_1* as well as a combination of both *RpS6_2* and *Muc14a_6* transgenes are shown. Control experiments consist of *βtub85D-cas9/+* (no gRNA) males crossed to *white* females. The table also shows the results from the cross between *nos_cas9/RpS6_2* males and *white* females. The last two columns in the table show the average number of F1 individuals per single cross and the fraction of experimental versus control (set as 1 for control) averages. Each cross was between one male and three females and at least ten independent single crosses per experiment were performed.

(XLSX)

###### 

Click here for additional data file.

###### Survival analysis of the F1 progeny of *RpS6_2/βtub85D-cas9* males crossed to *w* females compared to *w* and *βtub85D-cas9/+* control males crossed to *w* females.

F1 embryos were collected six, and five times from cages containing males of the genotype *RpS6_2/βtub85D-cas9*, *+/βtub85D-cas9* or *white* respectively, crossed to *white* females. The table shows the numbers of embryos, hatched embryos, pupae, females, males and total adults for each collection. The table also shows the percentages of pupae on collected embryos, adults on pupae, and frequencies of males and females on adults.

(XLSX)

###### 

Click here for additional data file.

###### Primers used in this study.

The table shows the primers name, description of where they were used and the corresponding nucleotide sequences. The gRNA sequences are underlined.

(XLSX)

###### 

Click here for additional data file.
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Reviewer \#1: In this study, the authors investigated mechanisms of X-shredders and "X-meddlers" in Drosophila melanogaster. The authors used their previously develop redKmer software to identify suitable repeats on the X-chromosome for shredding. Using autosomal split-Cas9 and gRNA lines, they found that only one gRNA was effective at shredding, and only Cas9 with the beta tubulin promoter, not nanos, despite the latter having overall more cleavage activity. This was likely due to the difference in expression timing between these promoters. The "X-meddler" involved targeting a haplolethal gene on the X-chromosome and represents the first experimental demonstration of a genetic control system based on this strategy (though the final proposed system would need to be on the Y chromosome). This strategy was also successful in biasing the sex ratio toward males.

This manuscript represents a solid step forward in the field and should be published in PLOS Genetics. Here's some comments on how the authors could potentially improve their manuscript (in roughly the order they appear in the text):

1\. The abstract is somewhat light on actual results. Maybe add 2-3 lines regarding the conclusions?

2\. In the introduction, the authors say, "This is because the fecundity of females, the sex with a lower rate of gamete production, generally determines the size of a population." While playing a bit part, I'm not sure if this is technically accurate, particularly given the high density-dependent mortality in mosquito larvae. I'd suggested softening the wording of this phrase.

3\. At the end of the first paragraph of the introduction, the authors may want to clarify that the experimental systems have the X-shredder allele on the autosome, so while a big step towards Driving Y elements, they don't have the power of the Driving Y/X-shredder described in the middle of the paragraph. Additionally, only one of these experimental systems was used in a cage study.

4\. It would be nice to have a good term for the X-linked haplolethal targeting strategy, but "X-meddling" is not very informative with regard to the goals of the meddling. I'd encourage the authors to reconsider the name. Maybe "X-poisoning" would be good? Perhaps "X-disrupting" if you want to be less flamboyant?

5\. a. For the second paragraph in the results, it may be helpful to mention the specific range of the rate of white-eye offspring for the βtub85D promoter, to make it clear why nanos works better here.

b\. Also "LbCfp1" should be "LbCpf1" in one spot. In general, be careful with your cpf1/Cas12a/LbCpf1 terminology.

c\. Also, this giant paragraph should probably be broken into smaller more focused paragraphs based on the white results, target determination, and results of the new constructs. I'd suggest adding subsection headings to the results as well.

d\. "the RpS5a (McKim, Dahmus, and Hawley 1996), RpS6 (Stewart and Denell 1993) ribosomal protein genes" should be "the RpS5a (McKim, Dahmus, and Hawley 1996) and RpS6 (Stewart and Denell 1993) ribosomal protein genes".

e\. Was the ability of Muc14a_1 and Muc14a_2 to disrupt the target confirmed, as in figure 2A?

6\. a. In the third paragraph of results, the authors use the phrase "the ubiquitous Pol III promoter of the Drosophila U6 snRNA gene", but I think they mean "the Pol III promoter of the Drosophila U6 snRNA gene that drives ubiquitous expression".

b\. The author write, "We also observed that the w_ex3_2 gRNA targeting white, when encoded

as the ultimate of four gRNAs within the array, showed a dramatically reduced level of activity (Figure 2B)." This should be Figure S1. This is likely due to saturation of the Cas9 activity by the gRNAs (this study covers multiplex gRNAs and Cas0 saturation and should be published in Science Advances soon: <https://www.biorxiv.org/content/10.1101/679902v1>), likely combined with reduced expression of gRNAs in time for cutting by last gRNA due to the tRNA system.

c\. Could the term "meiotic activity" be clarified, especially with respect to the usual expression pattern of the two promoters that are compared in the manuscript? For example, is it after meiosis I, or during all of meiosis?

7\. a. Statistics are missing on Figures 2C and 4C for the % males and % females (it's pretty clear, but probably good to add for completeness).

b\. Also, it may be better to eliminate the "%" from the category labels. It's already on the vertical axis, and it could create some confusion in some cases if people go through the figures too quickly (eg, "why don't the 40% males and 5% females add up to 100% in the brown part of Figure 4C).

c\. Also, the legend in 2C has "blue grey white", but the figure itself has "white grey blue".

d\. There is some redundancy in this figure that could potentially distort useful information. Instead of the current form, it might be better to use egg to pupae survival rates and pupae to adult survival rates instead of absolute % of eggs, and then just have a single column for sex ratio. The sample size could go into a supplement, clearing up the figure quite a bit and putting more focus on what is happening at each stage, rather than having to keep overall trends in mind.

e\. Any idea why the βtub85D-Cas9 line had lower hatch rates, especially in 2C?

8\. For Figure 4D, only the "A" in "ACC" and the "AT" in "ATG" are highlighted green. However, perhaps all three nucleotides should be highlighted in both cases, representing insertions where some of the nucleotides just happen to be similar to other parts of the sequence?

9\. Were the RpS5a and RpS6 targets tried with the nanos-Cas9 line? Since nanos seems to have higher activity, this might substantially increase efficiency. It would be cool to see a little bit of data for this and might be easy to do, but I don't consider it necessary if the authors don't have time before submitting their revision.

10\. I may have missed this, but could be better gRNAs simply have intrinsically more activity, rather than needed to invoke sequence microenvironments or other explanations? If this is true, it could possibly go against the conclusion that a single gRNA is best. Perhaps a cluster of different gRNAs that each are very active could still be superior, but if a superior gRNA is put with a cluster of inferior ones, it gets too "diluted" and total cleavage is reduced.

11\. It looks like the repeats fall within a narrow range, rather than scattered throughout the X-chromosome. Is this different than the Anopheles experiments? It might be worth commenting that targeting a narrow chromosomal window may actually improve the chance for successful repair (since the little pieces that form won't matter - only the big pieces need to be rejoined. If targets were scattered throughout, then each piece may need to be properly repaired, or at least lots of them). This may not have been seen when multiplexing gRNAs in the current study since only a limited number of gRNAs seemed to be highly active.

12\. Comma after "Chromosome-wide, distributed repeats represent an alternative set of targets".

13\. "Alternatively, the observed differences could also partly relate to the predominance of homologous over non-homologous DNA repair pathways acting with varying stringency during the early (including stem cells) and late stages of spermatogenesis, respectively (Chan et al. 2011)." Why would homology-directed repair impact X-shredding when no template for repair is available in males? Perhaps a simple explanation of nanos vs βtub85D X-shredding efficiency is that despite the greater overall activity of nanos, repair is highly efficient in pre/early meiosis and less so in late meiosis when βtub85D has higher activity?

14\. "The fly model of X-shredding we have established will allow to tackle these questions experimentally" should instead be something like this: "The fly model of X-shredding we have established will allow these questions to be tackled experimentally".

15\. Maybe comment that X-meddling may be easier to perform from the Y chromosome due to the need for reduced Cas9 activity (just one or a few cuts needed vs. potentially dozens or hundreds). Also, conserved sites wouldn't necessarily be needed if multiplexed gRNAs were used, as long as they all had good activity.

16\. Regarding the possibility of dominant negative mutants in the RpS genes, I think this may certainly be the case. However, could another possibility simply be that the gene isn't completely haplolethal, and that after passing a certain "critical" stage, likely in embryo development, the gene is haplosufficient? This may be a boring explanation in comparison, but it could explain why you detected some frameshift mutations in viable individuals. This could be assessed by crossing these females (presumably before sequencing) and observing if all the male progeny are viable (in which case, likely dominant negative) or if most are still nonviable (then likely not completely haplolethal). This could be left to a future study.

Minor note: For future submissions, I'd encourage the authors to put the figures and their legends "in-line" with the text if the journal allows submissions like this (I received the same advice when submitting a PLOS Genetics article a while ago, and so far, all journals I've worked with seem to allow this now). Bigger spaces between paragraphs would also make the manuscript easier to read.

Overall, good job by the authors. This manuscript should fit in well at PLOS Genetics. I am Jackson Champer, and I'm happy to clarify any of the above points if my wording doesn't make sense (<jc3248@cornell.edu>).

Reviewer \#2: This manuscript explores the general hypothesis that interfering with X chromosomes during spermatogenesis can impact the sex ratio of progeny derived from affected males. Such a mechanisms, known as X-shredding, has been show to be successful in the malaria mosquito, Anopheles gambiae, and has been proposed as a method for population suppression. However, aside from rare naturally occurring examples of biased sex chromosome transmission, little has been done in Drosophila to look at such systems - given the recent rise in the population of D. suzukii and other dipteran pests, a better understanding of potential genetic control strategies is welcome.

Here the work describes the application of two CRISPR-Cas9 based approaches; X-shredding, where X-specific repeats are targeted for cleavage in the male germline, and X-meddling, a proposed method for sex-biasing populations by targeting halo-insufficient loci such that the homogametic progeny die. Overall, the experiments are well designed and demonstrate that both methods can be applied in Drosophila, suggesting a broader applicability of the approaches, at least in diptera. Key new insights are the use of computational approaches to identify X-specific repeated DNA sequences and showing that at least in one situation targeting such a sequence can bias the sex ratio. Second, the experimental verification of the hypothesis of Burt and Deredec that targeting an X-linked haploinsufficient locus in the male germline could reduce the viability of XX progeny.

While overall the work is interesting and supports the further research into these proposed control mechanisms in a tractable system, I feel the current manuscript leaves much hanging. In particular, there is minimal discussion of, or investigation into, why only one of the Muc14a gRNAs is sucessfull in vivo; aspects of the mutation spectrum generated with the early nos-Cas9 driver versus the later B-tub-Cas9 are poorly explained, in particular the expected outcomes when repair is via HDR or NHEJ is poorly explored. I note that the use of the attached X stock to isolate cut chromosomes in the male is elegant, and the assays in repair pathway mutants are good. I found the discussion around Fig 4 patchy and lacking firm conclusions, while targeting two X-linked ribosomal protein genes did, as predicted, induce male biased progeny, the mechanism for this remains unclear and I would have expected more than just a suggestion it is a dominant effect.

In places the manuscript appears hastily prepared and lacks clarity, particularly in the early sections describing the generation and assay of the Cas9 lines.

Minor comments:

Pg3 & Fig S1- lack of clarity on the Cas9 lines used in the white assays.

FigS1 Legend is wrong \#20G on 2nd and \#20F and \#20G on 3rd

Pg3 & FigS2 & S3 - Lacks clarity on Redkmer selection - matches to Unmapped and unmapped extra reads should be properly explained.

Pg4 & Fig1 Results with esi2 seems odd, generating female bias, and is not commented upon

Pg4 why is there is no female control for Muc14a_6

Pg5 data on w with gRNA array is in fig S1not Fig 2

Pg5 Comment on the lethality associated with the Cas9 alone

Pg5 & Fig2C, male bias looks much less than in 2B?

Pg6 & Fig 3B - why less replicates with Control & nos-Cas9

Pg6 & Fig 3C - helpful if changes from wild type allele were highlighted

Reviewer \#3: In this paper, Fasulo and colleagues create experimental synthetic sex ratio distorters in Drosophila melanogaster. "X-shredding" and "X-meddling" are two distinct strategies that were confounded in previous experiments. The experiments in this paper demonstrate that "X-shredding" can work outside of mosquito and therefore could be promising for uses beyond malaria control.

I think that this paper is broadly interesting. I like that the authors report on differences in timing (nos versus Btub85D) and the induced mutations, as these experiments give some insight into the underlying repair processes. The methodology in the paper is straightforward. Below I make some suggestions that I hope will improve the manuscript.

Major comments:

I do not see any tables except for Table S1. I only see reference to Tables 1 and S1, 3 and 5 in the manuscript.

Figure 3 legend: "percentage of all mapping reads" is confusing. Do you mean the percentage of all mapped reads? These data should appear somewhere. In panel B, why do you think that the control only has 90%? Why would nos-cas9 have fewer unique alleles lacking full gRNA target site than the control?

Figures 2C and 4C: I think that you need a better description of the categories (e.g. % male and % female) in the legend. The % hatching is lower for Btub85-cas9/+ (Fig 2C). Is this chromosome different from the Btub85-cas920F used in X-meddler experiments?

Figure 3A: I like the schematic showing the PCR and amplicon sequencing but I had a few questions. Are the thin arrows the primers? And does the 153 bp region correspond to the repeat unit? What are the grey bars flanking the blue bar?

Ideally, the repeats targeted for X shredding would be X-specific for future applications, to reduce the chance of off target effects that may be transmitted. Although your sex ratio data show that the X chromosome is likely targeted, it would be good to give the reader an idea of how enriched these repeats are on the X chromosome. In Figure S2B, you show that the Muc14a target sites are frequent on 'Unmapped_Extra' and 'Unmapped' and so their locations are unknown. It may not be possible to figure out where all of these repeats are with current technology, but there are at least three things that you could do to add support for the majority of these repeats being X-linked: 1) FISH on polytene and mitotic chromosomes, 2) map to an assembly that has better representation of heterochromatin (<https://doi.org/10.1534/genetics.118.301765>), 3) plot Illumina depth in male vs female.

The proof-of-principle experiments described in this paper are a necessary and important step towards developing tools intended for vector control. However, I think that it is appropriate to add a sentence or two that mentions some of the caveats for using an X shredder designed to target X-linked repeats. For example, targeting an X-enriched repeat that is dispersed in the genome, or even dispersed on the chromosome, may cause genome rearrangements of unknown consequence that can be transmitted. I think that you need to know more about the targets and their distribution in the genome (and repair processes involving repeats).

Minor:

Figure 2: The figure was not completely clear to me ("a typical region of the Muc14a gene...") until I saw Figure 3. It might help to add more labels, or more description to the legend. Alternatively, combining with the schematic in Figure 3 could help.

Page 3: About the Drosophila X-linked repeats, it's not clear what you are comparing to when you say that they are less abundant.

Page 4: It would help to describe the target repeats in a bit more detail here (e.g. repeat unit, distribution, composition).

Pages 4 and 5: Cytology on sperm (e.g. FISH with X-satellite probe) may help you determine if these sperm are lost.

Pg 5, line 4 "the ultimate of four gRNAs" is unclear.

Page 6 lines 1-4: The wording here is hard to follow.

\*\*\*\*\*\*\*\*\*\*

**Have all data underlying the figures and results presented in the manuscript been provided?**

Large-scale datasets should be made available via a public repository as described in the *PLOS Genetics* [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability), and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: No: I could not find any tables except Table S1
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